Viewing Study NCT00515632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2026-05-07 @ 12:39 AM
Study NCT ID: NCT00515632
Status: COMPLETED
Last Update Posted: 2010-07-23
First Post: 2007-08-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy
Sponsor: Rheoscience A/S
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes mellitus on Stable insulin therapy View
None Balaglitazone View
None Pioglitazone (Actos®) View
None HbA1c View
None Weight gain View
None Oedema View
None Fasting blood glucose View